Codes / ICD10CM / B74.9

B74.9 Filariasis, unspecified

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Filariasis, unspecified

Summary

Filariasis, unspecified is a parasitic infection caused by thread-like nematodes (roundworms) of the family Filariidae. The condition is transmitted through the bite of infected mosquitoes and can lead to a range of clinical manifestations, including lymphatic damage, subcutaneous swelling, and ocular involvement. The disease is endemic in tropical and subtropical regions and may present with acute or chronic symptoms depending on the specific filarial species and host response.

Causes

Filariasis, unspecified is caused by infection with filarial nematodes, primarily Wuchereria bancrofti, Brugia malayi, or Brugia timori (lymphatic filariasis) and Loa loa, Mansonella streptocerca, or Onchocerca volvulus (subcutaneous/ocular filariasis). Transmission occurs when an infected mosquito bites a human, introducing larval parasites into the bloodstream. The larvae mature into adult worms, which reside in lymphatic vessels or subcutaneous tissues, producing microfilariae that circulate in the blood and are ingested by subsequent mosquito vectors.

Risk Factors

  • Residence in or travel to endemic tropical/subtropical regions where filarial vectors are prevalent.
  • Prolonged exposure to mosquito bites, particularly in areas with poor vector control.
  • Lack of access to preventive measures such as insect repellent or bed nets.
  • Immunocompromised states, which may increase susceptibility to severe disease.

Symptoms

  • Asymptomatic infection in some cases.
  • Acute lymphatic inflammation (lymphangitis) with fever, chills, and localized swelling.
  • Chronic lymphatic obstruction leading to lymphedema (swelling of limbs or genitalia).
  • Subcutaneous nodules or abscesses.
  • Ocular symptoms (e.g., eye pain, visual disturbances) in cases of ocular filariasis.
  • Eosinophilia (elevated eosinophil count) in blood tests.

Diagnosis

Diagnosis of filariasis, unspecified typically involves a combination of clinical evaluation, laboratory testing, and imaging. Microscopic examination of blood or tissue samples may reveal microfilariae. Serological tests (e.g., antigen or antibody detection) can confirm infection. Imaging studies (e.g., ultrasound, lymphangiography) may assess lymphatic damage. In cases of ocular involvement, slit-lamp examination or fundoscopy may be performed. A definitive diagnosis often requires correlation of clinical findings with laboratory or imaging results.

Treatment Options

Treatment for filariasis, unspecified depends on the specific filarial species, severity of symptoms, and patient factors. Antiparasitic medications (e.g., diethylcarbamazine, ivermectin, albendazole) are commonly used to target adult worms and microfilariae. Supportive care, such as compression therapy for lymphedema or antibiotics for secondary infections, may be necessary. In chronic cases, surgical intervention (e.g., lymphatic reconstruction) may be considered. Treatment plans should be tailored to the individual patient and guided by infectious disease specialists.

Prognosis and Follow-Up

The prognosis for filariasis, unspecified varies based on the extent of tissue damage and timely intervention. Early treatment can reduce symptoms and prevent progression, but chronic lymphatic damage may be irreversible. Regular follow-up is essential to monitor for recurrence, complications (e.g., elephantiasis), or treatment-related adverse effects. Patients should be educated on preventive measures (e.g., mosquito avoidance) to reduce reinfection risk.

Complications

  • Chronic lymphedema or elephantiasis (severe swelling of limbs/genitalia).
  • Secondary bacterial infections (e.g., cellulitis) due to skin breakdown.
  • Hydrocele (fluid accumulation in the scrotum) or genital deformities.
  • Ocular damage (e.g., blindness) in cases of onchocerciasis.
  • Eosinophilic meningitis or encephalitis (rare, associated with Angiostrongylus cantonensis or Baylisascaris procyonis).

Lifestyle & Prevention

  • Use insect repellent (e.g., DEET) and wear protective clothing to avoid mosquito bites.
  • Sleep under insecticide-treated bed nets in endemic areas.
  • Avoid outdoor activities during peak mosquito hours (dusk to dawn).
  • Practice good hygiene to reduce skin infections in areas of lymphedema.
  • Seek prompt medical care for suspected infections or exposure.

When to Seek Professional Help

Seek medical attention if you experience:

  • Unexplained swelling (especially in limbs or genitalia).
  • Fever, chills, or lymph node enlargement after travel to endemic regions.
  • Ocular symptoms (e.g., eye pain, vision changes).
  • Persistent skin lesions or abscesses.
  • Exposure to mosquitoes in tropical/subtropical areas with filariasis risk.

Tips for Medical Coders

When coding for filariasis, unspecified (B74.9), ensure documentation supports the diagnosis and absence of specific filarial species. Verify that clinical findings (e.g., lymphatic swelling, eosinophilia) align with the unspecified category. Document any relevant travel history, exposure, or diagnostic results to support medical necessity. Avoid using B74.9 if a specific filarial species is identified (e.g., Wuchereria bancrofti or Brugia malayi), as more precise codes exist for those conditions.

Book a walkthrough

B74.9 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.